Related by context. All words. (Click for frequent words.) 56 ResQNet 56 obiter 54 v. Teleflex Inc. 54 ipernica 53 KSR Int'l Co. 52 Justice Pumfrey 52 nonfinal 52 T-#/# [002] 52 CAFC reversed 52 patent invalidity 52 Allvoice 52 UKIPO 51 merely colorable 51 Appellant asserts 51 BPAI 51 C-#/# [001] 51 UCBR 50 CrR #.# 50 Rule #:#-# [002] 50 judicial estoppel 50 La.Civ.Code art 50 awardable 50 nonappealable 50 Patents Upheld 50 Summary Judgment Order 49 Patent Infringement Suit 49 rebuttable presumptions 49 Princo 49 reexamination proceeding 49 prosecution laches 49 substantively unconscionable 49 resolves patent infringement 49 Dkt 49 Competitive Impact Statement 48 accused infringer 48 CFR § #.# [006] 48 Nos. #-# [002] 48 procompetitive 48 interlocutory injunctions 48 VirnetX patents 48 noninfringement 48 Noerr Pennington 48 Title VII retaliation 48 Pa.RAP 48 Tessera patents 48 Patent Invalid 48 TrAIL Co. 48 Judge Saris 48 Preliminary Injunction Against 48 Petitioner argues 48 i4i patent 48 Dyna Torque 48 Reply Brief 48 CM ECF 48 Patent Infringement Claims 48 ADJUDGED 48 Card Activation 48 issue preclusion 48 ANDA applicant 48 Rehearing En Banc 48 Permanent Injunction 48 Evid 48 USSG § #G#.# 48 Cabilly 48 State ex rel 48 Daubert v. 48 Younger abstention 47 Akzo Nobel Chemicals 47 improvidently granted 47 patent infringment 47 Derivative Action 47 CFR § #.# [003] 47 Norwich Pharmacal 47 Patent Infringement Case 47 Spreigl evidence 47 factually unsupported 47 PMPRB 47 Friskit 47 mootness 47 CorePharma LLC 47 Justice Cowdroy 47 Third Amended Complaint 47 Aplt 47 inter partes 47 Patent Validity 47 Fed.R.Civ.P. 47 Uniloc patent 47 Judge Birss 47 CFR § #.# [001] 47 Datasci 47 Saffran patent 47 Petitioner contends 47 ED Tex. 47 Declaratory Judgment 47 Iridex 47 Therasense 47 hereby ORDERED 47 Aerotel 46 Para IV 46 Amphastar 46 Wins Patent Infringement 46 Lilly Evista 46 OCGA § #-#-# [007] 46 Occlutech 46 Relators 46 Patent Infringement Lawsuit 46 Markman Hearing 46 CAFC affirmed 46 Nasdaq Delisting 46 Justice Perram 46 antitrust counterclaims 46 vacatur 46 w hether 46 postjudgment 46 Bestex 46 spokesman Guy Esnouf 46 additur 46 ex mero motu 46 Alphapharm 46 contemporaneous documentation 46 Hodari D. 46 p laintiff 46 prima facia 46 § #-#-# c [001] 46 Civil Procedure Rule 46 Movants 46 equitable subordination 46 Code Civ 46 Case C-#/# [002] 46 frivolous vexatious 46 CFR #.# c 46 preclusive 46 habeas proceeding 46 Compl. ¶ 46 § #-#.# [004] 46 Circuit CAFC 46 claim preclusion 46 counterclaims asserted 46 USSG § 46 § #:# [001] 46 LunarEye 46 adequately pled 46 Inequitable Conduct 46 patently unreasonable 46 '# patent invalid 46 Dismiss Plaintiff 45 Liability Lawsuits 45 patent reexamination 45 summarily affirm 45 Judge Sabraw 45 MRTP Commission 45 Case T-#/# 45 classwide arbitration 45 Tamoxifen Citrate 45 Collateral estoppel 45 Files Patent Infringement 45 orig. proceeding 45 Lemelson patents 45 Final Judgments 45 Pitchess discovery 45 DG COMP 45 Teva Parenteral Medicines 45 ex turpi causa 45 Nasdaq Delisting Notice 45 § #-#-# [002] 45 Patent Infringement Litigation 45 Slip op 45 PharmaStem 45 interrogatory responses 45 replead 45 jurisdictional prerequisite 45 Defendant asserts 45 Ariad patent 45 CFR § #.# [008] 45 ECJ judgment 45 Kiobel 45 2d Dept 45 § #.# [003] 45 END FOOTNOTE 45 Bilski patent 45 Second Amended Complaint 45 Patent Lawsuit 45 Mofcom 45 Ravicher 45 Okla. Stat 45 Appeal Tribunal CAT 45 nonjurisdictional 45 Patent Ruling 45 SDNY Mar. 45 sub nom 45 Requester 45 Non Infringement 45 Speedus 45 Ark. R. Civ 45 Defendants Motion 45 v. Siracusano 45 Xpoint 45 nonobviousness 45 Elumina Iberica SA 45 declarants 45 Infringed 45 compensability 45 ALJ Initial Determination 45 validity enforceability 45 facially invalid 45 dispositive motions 45 ore tenus 45 LSA RS #:# [002] 45 Favorable Ruling 45 Plaintiff asserts 45 Plaintiff Complaint 45 Enpath 45 negligent misstatement 45 procedurally flawed 45 JNOV motion 45 coram nobis relief 45 Appellate Panel 45 anticompetition 45 inapplicability 45 d efendants 44 § #a [002] 44 Restatement § 44 generic Copaxone 44 QPSX 44 inter partes reexamination 44 Patent Infringement 44 arguable merit 44 First Instance CFI 44 ÚOHS 44 KSR v. Teleflex 44 Noerr Pennington doctrine 44 inter partes re 44 Patent Reexamination 44 HIMC Corporation 44 equitable subrogation 44 First Amended Complaint 44 reh'g denied 44 equitable estoppel 44 Dkt. # 44 Judge Luckern 44 sua sponte duty 44 affirmance 44 Mohan Sekhar 44 laches 44 § #E 44 appellant contends 44 nonfrivolous 44 CysDisplay 44 DG Comp 44 manifestly erroneous 44 meritorious defenses 44 § #A.# 44 Amended Judgment 44 evidence preponderates 44 Neuftec 44 HRS § #-# [001] 44 TCA § #-#-# [003] 44 Rooker Feldman doctrine 44 NJRE 44 corpus delicti rule 44 SEC Rule #g# 44 s#A [002] 44 parol evidence 44 RCEs 44 Listings Qualification Panel 44 Metabolite 44 Joy Lud 44 presumptively valid 44 exculpatory clause 44 equitable mootness 44 JNOV 44 Appellants argue 44 Initiates Patent Infringement 44 GlycoGenesys 44 coram nobis 44 Bell Atl 44 Copyright Royalty Judges 44 PRRB 44 Hr'g Tr 44 SLUSA 44 DC Code § 44 legitimate nondiscriminatory 44 bsent 44 UCB Pharma SA 44 collaterally estopped 44 AADB 44 WCAB 44 Notification Related 44 responsive pleadings 44 CFR § #.# [004] 44 willful patent infringement 44 uncontroverted facts 44 p rior 44 Ex parte Young 44 First Instance upheld 44 Strickland supra 44 Premarket Approval 44 See USSG 44 Patent Infringement Action 44 Ansac 44 Sentencing Guidelines Manual 44 nonstatutory 44 restitutionary 44 anticircumvention 44 IPCom 44 Tennard 43 estoppel 43 Defendants Motions 43 appellant asserts 43 appellant contentions 43 Obviousness 43 JMOL 43 Penalty Guidelines 43 Dkt. 43 interlocutory appeals 43 Defendant Motion 43 Pitchess motion 43 TecSec 43 interlocutory judgment 43 pari delicto 43 homocysteine assay 43 SCR #:#.# [001] 43 § #A [002] 43 procedurally defective 43 Appellants contend 43 dkt 43 Finjan patents 43 CJEU 43 p laintiffs 43 reh'g 43 Patent Lawsuit Against 43 DataTern 43 Memorandum Opinion 43 SOX whistleblower 43 Tenn. R. Civ 43 FFDCA 43 Confirms Validity 43 § #-#-# [006] 43 w ithout 43 Plaintiffs assert 43 Injunctive relief 43 section #.#b 43 MSPB 43 collateral estoppel 43 CALJIC 43 De Varon 43 factual determinations 43 § #-#.# [002] 43 NASDAQ Delisting Notice 43 ORS #B.# 43 Wider Networks 43 Settling Parties 43 procedural reasonableness 43 NFTL 43 Interdigital 43 People v. Doganiere 43 Minn. R. Civ 43 interlocutory orders 43 USSG § #B#.# [002] 43 untimeliness 43 CFR § #.# [002] 43 Megace R 43 section #.#.# 43 Nasacort 43 mere scintilla 43 App.R. 43 Plaintiffs Complaint 43 § #-#-# b [002] 43 factual predicate 43 No. B# 43 Interpretative Communication 43 KSA #-# [001] 43 Appellants assert 43 OPTi 43 Entology 43 Minn. R. Evid 43 2d Cir.# 43 proximate causation 43 RC #.# B [002] 43 Claimant argues 43 IRCP 43 unpatentable 43 appellants contend 43 posttrial 43 § #K#.# b 43 anticipatory repudiation 43 Evid. Code § 43 NJSA #:#-#.# [003] 43 Claimant contends 43 asserted counterclaims 43 KKPC 43 qui tam relator 43 uncharged misconduct 43 procedural unconscionability 43 Seabed Logging 43 Attenex Patterns 43 factually distinguishable 43 parol evidence rule 43 Xterasys 43 equitable indemnity 43 Riegel v. 43 TRAB 43 FAT filesystem 43 NJSA 2A #A 43 c ounsel 43 Patent Litigation 42 VNUS patents 42 reviewed de novo 42 § #-#.# [001] 42 granted certiorari 42 postconviction counsel 42 NYCHRL 42 NJSA #:#-#.# [001] 42 Pending Litigation 42 Petitioner asserts 42 Bruesewitz v. 42 Simplified Procedure 42 Justice Charleton 42 Final Appraisal Determination 42 Determinations 42 False Marking 42 Initial Determination 42 tunc 42 nonfrivolous issues 42 subsection h 42 GEOSPAN 42 AATI 42 Case No. A#A# 42 Munby J 42 IPONZ 42 Aerocrine 42 Time Warp patent 42 BATCo 42 RapMAT 42 Metoprolol Succinate 42 Reinholtsen 42 See Restatement Second 42 particularity requirement 42 Invalidation 42 Cabilly patent 42 ND Tex. 42 dism'd 42 C-#/# [002] 42 La. Code Civ 42 Judgments § 42 GRADE certification 42 en banc rehearing 42 doc. 42 IJ erred 42 xxxi adverse tax 42 InterDigital patents 42 CALJIC No. #.# 42 La.Code Crim.P. art 42 generic Lovenox 42 Judge Gajarsa 42 Lord Glennie 42 de minimis exception 42 Res judicata 42 § #-#-# [004] 42 Intellipharmaceutics 42 Judge Preska 42 CFR § #.# [005] 42 QbD 42 CFR § #.# [007] 42 allowability 42 unconscionability 42 Elias Zacarias 42 u pon 42 No. #-# Fed. 42 Inpro 42 precluded summary judgment 42 § #c 42 Reply Br 42 Uniloc 42 contributory infringement 42 v. Kappos 42 Balluck 42 Justice Venning 42 Declaratory Judgment Act 42 Noveko TM 42 therapeutic equivalence 42 Settling Defendants 42 contributory trademark infringement 42 Va. Code § 42 SEBI Takeover Code 42 overbreadth 42 inventorship 42 unduly prejudicial 42 § 7A 42 Tribunal CSRT 42 Plaintiff Motion 42 BALCA 42 Anchen Pharmaceuticals 42 PAJA 42 Issued Patent 42 suspensive effect 42 JUSTICE STEVENS 42 OOR 42 order sustaining demurrer 42 § #C#.# 42 Evid.R. 42 Rev. Rul 42 hereby DISMISSED 42 Rix LJ 42 reasonably arguable 42 v. Grokster Ltd. 42 Medify Solutions Limited 42 Undisputed Facts 42 R. #:#-# 42 Doc. # 42 OCGA § #-#-# [006] 42 International v. Teleflex 42 patent infringer 42 Plaintiff contends 42 FRAND 42 Formal Dispute Resolution 42 Gzell 42 rebuttable 42 Pl. s 42 Determinations Panel 42 BNetzA 42 #-# SDNY 42 ClearCorrect 42 hereby GRANTED 42 Rule #:#-# [001] 42 factual sufficiency 42 Rosenkrantz supra 42 ZapMedia applied 42 Advanced Analogic 42 lodestar method 42 Patent Upheld 42 Court. Judgment 42 Paul Luckern 42 e vidence 42 severability provision 42 reexamination proceedings 42 § #B#.# [002] 42 Hearings Panel 42 justiciable controversy 42 patentee 42 CESTAT 42 deportability 42 legally protectable 42 La. RS #:# [003] 42 WAC #-#-# 42 IANAL 42 establishes prima facie 42 HRS § #-# [002] 42 Deltafina 41 DCAA audit 41 Innovatier 41 P laintiffs 41 Patentability 41 assuming arguendo 41 La. RS #:# [002] 41 Guardrisk 41 Colo. Sess 41 § #E#.# 41 Fla. 3d DCA 41 Markman Order 41 patented invention 41 Rooker Feldman 41 Consuelo Scerri Herrera 41 GeneCards R 41 Directive #/#/EC [006] 41 remittitur 41 anti SLAPP motions 41 § #-#-# b [001] 41 dispositive motion 41 scientifically invalid 41 #:# cv# [001] 41 Section #B#.# 41 Appellate Division affirmed 41 JK Sucralose 41 Judge Maraman 41 journalized 41 patentable 41 Civil Procedure Sec 41 ZHB 41 Equitable tolling 41 counsel performed deficiently 41 ORS #.# [001] 41 obviousness rejection 41 § #.# [002] 41 noninfringing 41 Romer CimCore 41 Levicom 41 intellectualproperty 41 APP STORE 41 SolidDB 41 Perlegoses 41 manifestly unreasonable 41 Justice Gzell 41 fraudulent joinder 41 contemplated therein 41 SASSA tender 41 VACATE 41 ll.# 41 Zuma Thint 41 Patent Infringement Lawsuit Against 41 patentable invention 41 rehearing en banc 41 substantive unconscionability 41 Impax Labs 41 La. RS #:# [001] 41 ipIQ 41 Fischer Zoth 41 mootness doctrine 41 Patent Dispute 41 WITH PREJUDICE 41 FEHA 41 judgment nunc pro 41 Simed 41 Final Determination 41 Domestic Spying Inquiry Restarted 41 Inc. v. PSKS 41 reweigh 41 DFEH 41 Plaintiffs Appellees 41 Justice Rares 41 En Banc 41 LIRC 41 WDNY 41 objectively verifiable 41 contemporaneous objection 41 RCW #.#A.# 41 Air Products NanoMaterials 41 § #-#.# [003] 41 preliminary injunctive relief 41 parental unfitness 41 Eleventh Circuit affirmed 41 constitutes patentable 41 Barr ANDA 41 Stallion Oilfield 41 Plaintiffs Counsel 41 Bedkes 41 Nken 41 RECALL VAX TM 41 arbitrable 41 reasonable factfinder 41 SD Tex. 41 postjudgment interest 41 argument unpersuasive 41 Summary Judgment Motion 41 Interferences BPAI 41 MR Civ 41 USCS § 41 DFARS 41 CleverPath Aion 41 Accelerated Approval 41 Justice Perell 41 Helvea analyst Olav Zilian 41 Biolitec 41 summary judgment de novo 41 PhotoCure 41 IIRIRA 41 patentees 41 NASDAQ Listing Qualification 41 App'x 41 Practice Direction 41 M Enoxaparin 41 InNova 41 Inducement Awards 41 Remedies Directive 41 NHSLA 41 Schweizerhall 41 evYsio 41 OCGA § #-#-# [005] 41 PLAVIX ® 41 patentably distinct 41 USDOC 41 nonsuit 41 Eolas patent 41 highly leveragable 41 facially neutral 41 Visa Check MasterMoney 41 Acceris 41 Defendant Scrushy 41 NJSA #:#-# [004] 41 Adversary Proceeding 41 Uniform Dispute Resolution 41 summary affirmance 41 LSA RS #:# [001] 41 Appeal Tribunal EAT 41 subsidiarity principle 41 movants 41 NexPrise 41 Ohio Adm.Code 41 Justice Kathryn Mickle 41 promissory estoppel claim 40 Justice Lewison 40 antirust 40 CAFA jurisdiction 40 RESTATEMENT SECOND OF 40 promissory fraud 40 DISH DVRs 40 reexamination certificate 40 9th Cir.# 40 injunctive action 40 preclude summary judgment 40 ANDA filer 40 NDA BLA 40 Ms Justice Laffoy 40 premerger notification 40 Betaseron ® 40 Board ASLB 40 jurisdictional defect 40 C ourt 40 Supplementary Product Disclosure 40 Mohd Diah 40 Corporate Governance Principles 40 Hatch Waxman Amendments 40 Order Granting 40 promissory estoppel 40 Amicus Briefs 40 Entocort 40 Restatement Second 40 bioequivalency 40 Rule #:#-# b 40 OCGA § #-#-# [004] 40 Mohamad Zabidin 40 wholly unsupported 40 quoting Twombly 40 Therapeutic Diagnostics 40 articulable 40 colorable claim 40 property Detournel 40 Judge Selna 40 Justice Toulson 40 curative instruction 40 WL # [002] 40 Synthon 40 procedurally unconscionable 40 fi ndings 40 inferable 40 Minn. R. Crim 40 Retamco 40 Nazomi 40 spokesman Tony Plohoros 40 Ipernica 40 Intermec RFID patents 40 Justice Baragwanath 40 Voluntary Dismissal 40 Anascape patent 40 Justice Dotse 40 dispositional orders 40 Anascape 40 FAS# [003] 40 Francois Legros 40 nondischargeability 40 CPLR 40 IJ adverse 40 Vnus 40 Ninestar 40 NASDAQ Listing 40 Plavix patent 40 Patent Suit Against 40 willfully infringing 40 mandamus proceeding 40 vicarious infringement 40 summary judgment motions 40 Faretta 40 v OHIM 40 Lucky Litter 40 USITC 40 Anchen 40 § #-#-# [005] 40 nontestimonial 40 patentability 40 SLAPP statute 40 Competition Appellate Tribunal 40 Mary Finlay Geoghegan 40 APP STORE trademark 40 Novopharm 40 Appellant contends 40 internal quotation omitted 40 mem. op 40 Justice Evans Lombe 40 Counterclaims 40 nolo contendere plea 40 s#A [001] 40 DDTC 40 Rule #b# 40 statutory aggravators 40 MPEP § 40 '# Patent 40 misapprehends 40 FURTHER ORDERED ADJUDGED AND 40 construe statutes 40 DMCA takedown 40 www.mirror.co.uk rules 40 '# patent 40 OPSI 40 meritless litigation 40 ARS § 40 Justice Abutu 40 transaction significantly undervalues 40 ADAAG 40 Bundesgerichtshof 40 Wyo. Stat 40 HCJ 40 unmeritorious 40 Ms Rebstock 40 ERISA § 40 unliquidated damages 40 Declaratory Order 40 reexaminations 40 Justice Tariq Parvez 40 legally supportable 40 CFR #.# [005] 40 Respondent contends 40 Stipulated Judgment 40 Judge Sprizzo 40 MEMO/#/# [002] 40 HTS MTP 40 mandamus petition 40 prejudicially affected 40 Patentees 40 manifestly unsupported 40 precedential 40 inter parte 40 Settles Patent Litigation 40 Judge Dyk 40 Listings Qualifications Panel 40 Nucleonics 40 inequitable conduct 40 quinapril 40 Procedure Code 40 Appellate Body 40 res ipsa 40 PKOP 40 patently frivolous 40 unanimity instruction 40 BugScope 40 OCGA § #-#-#.# 40 Sinorgchem 40 docketing 40 Pentalpha 40 determinations de novo 40 gross disproportionality 40 willfully infringe 40 plainly erred 40 Standard MGN 40 Stipulation Agreement 40 precedential value 40 supersedeas 40 supplemental biologics 40 pecuniary penalties 40 Forgent Networks 40 Justice Mohamad Zabidin 40 inspectional observations 40 JFTC 40 auditors KPMG LLP 40 fraudulent inducement 40 disapplied 40 Johnson v. Eisentrager 40 posttrial motions 40 Time Warp Patent 40 TPSAC 40 NASD Rule 40 OTC IPXL 40 quantum meruit 40 n.5 40 Justice Liam McKechnie 40 Adversary Complaint 40 GL c 40 REMAND 40 Crivella West 40 colorable 40 C ourts 40 DMEPOS supplier 40 Nastel Technologies 40 Preliminary Injunction 40 compulsory counterclaim 40 Power Integrations patents 40 EUclaim 40 Tafas v. Doll 40 ICSID tribunal 39 PSKS 39 Defendants 39 nonmovant 39 Proximate cause 39 Mr Margaretic 39 Judge Kollar Kotelly 39 Consumer Protection UOKiK 39 antenuptial agreement 39 Versata Enterprises 39 Mucotrol 39 factual contentions 39 § #b [003] 39 Amended Motion 39 Justice Kornreich 39 Akcros 39 Nasdaq Delisting Notification 39 Amended Petition 39 Bankr. D. Del. 39 lawyer Babatunde Irukera 39 lenity 39 USEI 39 CIETAC 39 scienter requirement 39 Cenvat Credit 39 CFR #.# [008] 39 adduce evidence 39 ALJ erred 39 FlowGuard 39 Section #.#.# [001] 39 Judge Scheindlin 39 Accelerated Examination 39 CENVAT Credit 39 '# patents 39 Justice Hedigan 39 IPXL 39 adopting IFRS 39 patent litigations 39 NanoCrystal Technology 39 non infringement invalidity 39 Rent Stabilization Code 39 Std Trinity Mirror 39 Debtor asserts 39 IGF 1R inhibitor 39 hereby DENIED 39 § #.#.# [002] 39 Preliminary Objection 39 dispositional order 39 CPLR § 39 CHRT 39 Ajaxo 39 SecurityExpressions 39 Justice Tamberlin 39 Mr Cacopardo 39 Sepracor patents 39 Centrality Communications 39 TUPE transfer 39 TiVo Time Warp 39 RCr 39 s.# [001] 39 plainly erroneous 39 Sunesis Pharma 39 Forgent patent 39 § #-#-# [001] 39 Mr. Narmont 39 verification ABV 39 Fla. 2d DCA 39 JUSTICE SCALIA 39 Antitrust Litigation 39 Declaratory Relief 39 antiretaliation provision 39 Settle Patent Litigation 39 CFR #.# d 39 ECJ 39 Leapstone Systems 39 procedurally improper 39 unduly prejudiced 39 O'Scannlain 39 Apprendi 39 Appellants 39 Consent Judgment 39 habeas petitioner 39 Co. v. Teleflex 39 racemate 39 Scheduling Order 39 willfully infringed TiVo 39 USC § #f 39 USC § #a [001] 39 error coram nobis 39 substantive reasonableness 39 de minimus 39 chairwoman Paula Rebstock 39 appellants 39 § #G#.# 39 Muhammad Shafee 39 unreasonably burdensome 39 constitutionally deficient 39 rev'd 39 n.8 39 contractual indemnification 39 § #A [003] 39 Interferences 39 ripeness doctrine 39 adduce sufficient 39 b Vernon Supp 39 sanctionable conduct 39 See USSG § #B#.# 39 Listing Qualifications Panel 39 BRILINTA 39 Tom Steipp 39 USC § #A 39 legally tenable 39 Wis. Stat 39 Crim.R. 39 Adarand 39 Suraya Othman 39 Objections SO 39 MVPDs 39 § #.# subd [005] 39 WARF patents 39 CAFC 39 severability